+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Head And Neck Cancer (Oncology) - Drugs In Development, 2021

  • PDF Icon

    Report

  • 4327 Pages
  • August 2021
  • Region: Global
  • Global Markets Direct
  • ID: 5438167
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide 'Head And Neck Cancer - Drugs In Development, 2021', provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape. Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights


This report provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 23, 257, 225, 4, 8, 172, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 14, 12, 1, 25, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to Buy


  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Introduction

Head and Neck Cancer - Overview

Head and Neck Cancer - Therapeutics Development

Head and Neck Cancer - Therapeutics Assessment

Head and Neck Cancer - Companies Involved in Therapeutics Development

Head and Neck Cancer - Drug Profiles

Head and Neck Cancer - Dormant Projects

Head and Neck Cancer - Discontinued Products

Head and Neck Cancer - Product Development Milestones

Appendix

List of Tables
  • Number of Products under Development for Head and Neck Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Head and Neck Cancer - Pipeline by 2A Pharma AB, 2021
  • Head and Neck Cancer - Pipeline by 4D Pharma Plc, 2021
  • Head and Neck Cancer - Pipeline by 4SC AG, 2021
  • Head and Neck Cancer - Pipeline by A2 Biotherapeutics Inc, 2021
  • Head and Neck Cancer - Pipeline by Aadi Bioscience Inc, 2021
  • Head and Neck Cancer - Pipeline by ABBA Therapeutics AG, 2021
  • Head and Neck Cancer - Pipeline by AbbVie Inc, 2021
  • Head and Neck Cancer - Pipeline by Abion Inc, 2021
  • Head and Neck Cancer - Pipeline by Accendatech Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Achilles Therapeutics UK Ltd, 2021
  • Head and Neck Cancer - Pipeline by Actuate Therapeutics Inc, 2021
  • Head and Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, 2021
  • Head and Neck Cancer - Pipeline by ADC Therapeutics SA, 2021
  • Head and Neck Cancer - Pipeline by Adlai Nortye Biopharma Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Advanced Accelerator Applications SA, 2021
  • Head and Neck Cancer - Pipeline by Advaxis Inc, 2021
  • Head and Neck Cancer - Pipeline by Advenchen Laboratories LLC, 2021
  • Head and Neck Cancer - Pipeline by Adze Biotechnology Inc, 2021
  • Head and Neck Cancer - Pipeline by Affimed GmbH, 2021
  • Head and Neck Cancer - Pipeline by AGC Biologics SpA, 2021
  • Head and Neck Cancer - Pipeline by Agenus Inc, 2021
  • Head and Neck Cancer - Pipeline by Akeso Inc, 2021
  • Head and Neck Cancer - Pipeline by Alkermes Plc, 2021
  • Head and Neck Cancer - Pipeline by Alligator Bioscience AB, 2021
  • Head and Neck Cancer - Pipeline by Alphageneron-Pharmaceuticals Inc, 2021
  • Head and Neck Cancer - Pipeline by Alphamab Oncology, 2021
  • Head and Neck Cancer - Pipeline by ALX Oncology Holdings Inc, 2021
  • Head and Neck Cancer - Pipeline by Ambrx Biopharma Inc, 2021
  • Head and Neck Cancer - Pipeline by amcure GmbH, 2021
  • Head and Neck Cancer - Pipeline by Amgen Inc, 2021
  • Head and Neck Cancer - Pipeline by AMI Onco Theranostics LLC, 2021
  • Head and Neck Cancer - Pipeline by AnBogen Therapeutics, 2021
  • Head and Neck Cancer - Pipeline by ANP Technologies Inc, 2021
  • Head and Neck Cancer - Pipeline by Anteris Technologies Ltd, 2021
  • Head and Neck Cancer - Pipeline by AP Biosciences Inc, 2021
  • Head and Neck Cancer - Pipeline by Apexigen Inc, 2021
  • Head and Neck Cancer - Pipeline by Apollomics Inc, 2021
  • Head and Neck Cancer - Pipeline by Arch Oncology Inc, 2021
  • Head and Neck Cancer - Pipeline by Arcus Biosciences Inc, 2021
  • Head and Neck Cancer - Pipeline by Immvira Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Imugene Ltd, 2021
  • Head and Neck Cancer - Pipeline by IMV Inc, 2021
  • Head and Neck Cancer - Pipeline by Incyte Corp, 2021
  • Head and Neck Cancer - Pipeline by Infinity Pharmaceuticals Inc, 2021
  • Head and Neck Cancer - Pipeline by Inhibrx Inc, 2021
  • Head and Neck Cancer - Pipeline by Innate Pharma SA, 2021
  • Head and Neck Cancer - Pipeline by InnoMab Pte Ltd, 2021
  • Head and Neck Cancer - Pipeline by Innovene, 2021
  • Head and Neck Cancer - Pipeline by Shanghai Jing Ze Biotechnology Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Shanghai Junshi Bioscience Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Shanghai Miracogen Inc, 2021
  • Head and Neck Cancer - Pipeline by Shanghai Novamab Biopharmaceuticals Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Shattuck Labs Inc, 2021
  • Head and Neck Cancer - Pipeline by Shenghe (China) Biopharmaceutical Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Shionogi & Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, 2021
  • Head and Neck Cancer - Pipeline by Silverback Therapeutics Inc, 2021
  • Head and Neck Cancer - Pipeline by Simcha Therapeutics Inc, 2021
  • Head and Neck Cancer - Pipeline by Sino Biopharmaceutical Ltd, 2021
  • Head and Neck Cancer - Pipeline by Sirnaomics Inc, 2021
  • Head and Neck Cancer - Pipeline by Sirona Therapeutics Inc, 2021Head and Neck Cancer - Pipeline by SQZ Biotechnologies


List of Figures
  • Number of Products under Development for Head and Neck Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 2A Pharma AB
  • 4D Pharma Plc
  • 4SC AG
  • A2 Biotherapeutics Inc
  • Aadi Bioscience Inc
  • ABBA Therapeutics AG
  • AbbVie Inc
  • Abion Inc
  • Accendatech Co Ltd
  • Achilles Therapeutics UK Ltd
  • Actuate Therapeutics Inc
  • Adaptimmune Therapeutics Plc
  • ADC Therapeutics SA
  • Adlai Nortye Biopharma Co Ltd
  • Advanced Accelerator Applications SA
  • Advaxis Inc
  • Advenchen Laboratories LLC
  • Adze Biotechnology Inc
  • Affimed GmbH
  • AGC Biologics SpA
  • Agenus Inc
  • Akeso Inc
  • Alkermes Plc
  • Alligator Bioscience AB
  • Alphageneron-Pharmaceuticals Inc
  • Alphamab Oncology
  • ALX Oncology Holdings Inc
  • Ambrx Biopharma Inc
  • amcure GmbH
  • Amgen Inc
  • AMI Onco Theranostics LLC
  • AnBogen Therapeutics
  • ANP Technologies Inc
  • Anteris Technologies Ltd
  • AP Biosciences Inc
  • Glycomantra Inc
  • GlycoMira Therapeutics Inc
  • Glycostem Therapeutics BV
  • Glycotope GmbH
  • Gossamer Bio Inc
  • GT Biopharma Inc
  • Guangzhou Bairui Biomedical Technology Co Ltd
  • Guangzhou BeBetter Medicine Technology Co Ltd
  • Guangzhou Doublle Bioproduct Inc
  • Guangzhou Hanghua Bio Pharmaceutical Technology Co
  • Guangzhou Sinogen Pharmaceutical Co Ltd
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Harbour BioMed (Guangzhou) Co Ltd
  • HDT Bio Corp
  • Henan Topfond Pharmaceutical TCM Co Ltd
  • Hengenix Biotech Inc
  • Hercules Pharmaceuticals BV
  • HitGen Inc
  • Hookipa Pharma Inc
  • Horizon Therapeutics Plc
  • Huabo Biopharm (Shanghai) Co Ltd
  • Hummingbird Bioscience Pte Ltd
  • HylaPharm
  • I-Mab
  • Ideaya Biosciences Inc
  • Idera Pharmaceuticals Inc
  • IGM Biosciences Inc
  • ImCheck Therapeutics SAS
  • ImmuneSensor Therapeutics Inc
  • Immunicum AB
  • ImmunityBio Inc
  • Immunocore Holdings Plc
  • Immunogenesis Inc
  • Immunomic Therapeutics Inc
  • Immutep Ltd
  • Immvira Co Ltd
  • Imugene Ltd
  • IMV Inc
  • Incyte Corp
  • Infinity Pharmaceuticals Inc
  • Inhibrx Inc
  • Innate Pharma SA
  • InnoMab Pte Ltd
  • Innovene
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • Instil Bio UK Ltd
  • Intensity Therapeutics Inc
  • InteRNA Technologies BV
  • Invectys SA
  • InxMed Shanghai Co Ltd
  • IO Biotech ApS
  • Iovance Biotherapeutics Inc
  • ISA Pharmaceuticals BV
  • Istari Oncology Inc
  • iSTAT Therapeutics Inc
  • ISU ABXIS Co Ltd
  • iTeos Therapeutics Inc
  • Jacobio Pharmaceuticals Group Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Jiangsu Vcare PharmaTech Co Ltd
  • Jina Pharmaceuticals Inc
  • Johnson & Johnson
  • Joint Biosciences Ltd
  • Jounce Therapeutics Inc
  • Karyopharm Therapeutics Inc
  • Kintara Therapeutics Inc
  • Komipharm International Co Ltd
  • Kuur Therapeutics Ltd
  • Kymab Ltd
  • Kyowa Kirin Co Ltd
  • L.E.A.F. Pharmaceuticals LLC
  • Laboratoires Pierre Fabre SA
  • LATITUDE Pharmaceuticals Inc
  • Leucid Bio Ltd
  • Lidds AB
  • LIfT BioSciences Ltd
  • LightOx Ltd
  • Linnaeus Therapeutics Inc
  • Lion TCR Pte Ltd
  • LipoSeuticals Inc
  • Luminus Biosciences Inc
  • Luye Pharma Group Ltd
  • Luzitin SA
  • Lycera Corp
  • LynkCell Inc
  • Lytix Biopharma AS
  • Mabion SA
  • Mabpharm Ltd
  • MacroGenics Inc
  • MAIA Biotechnology Inc
  • Marsala Biotech Inc
  • Mateon Therapeutics Inc
  • Maverick Therapeutics Inc
  • MaxiVAX SA
  • MediciNova Inc
  • Mekanistic Therapeutics LLC
  • Merck & Co Inc
  • Merck KGaA
  • Mereo Biopharma Group Plc
  • Mersana Therapeutics Inc
  • Merus NV
  • Metaclipse Therapeutics Corp
  • Millennium Pharmaceuticals Inc
  • MiNK Therapeutics Inc
  • Mirati Therapeutics Inc
  • MiRecule Inc
  • MiReven Pty Ltd
  • Mitsubishi Tanabe Pharma Corp
  • Moderna Inc
  • Modra Pharmaceuticals BV
  • Molecular Partners AG
  • Molecular Templates Inc
  • Moleculin Biotech Inc
  • Morphogenesis Inc
  • MultiVir Inc
  • Nanjing Iaso Biotherapeutics Co Ltd
  • Nanjing Sanhome Pharmaceutical Co Ltd
  • NanoCarrier Co Ltd
  • NantBioScience Inc
  • Natco Pharma Ltd
  • Nektar Therapeutics
  • Neonc Technologies Inc
  • NeoTX Therapeutics Ltd
  • Neumedicines Inc
  • NextCure Inc
  • NGM Biopharmaceuticals Inc
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Noxopharm Ltd
  • Nubiyota LLC
  • Obsidian Therapeutics Inc
  • Ocellaris Pharma Inc
  • Ona Therapeutics SL
  • OncoC4 Inc
  • Oncolys BioPharma Inc
  • Onconova Therapeutics Inc
  • Oncorus Inc
  • OncoSec Medical Inc
  • Oncovir Inc
  • OncXerna Therapeutics Inc
  • Ono Pharmaceutical Co Ltd
  • Onxeo SA
  • Ovensa Inc
  • Oxford Vacmedix UK Ltd
  • Pact Pharma Inc
  • Papivax LLC
  • PDS Biotechnology Corp
  • Pfizer Inc
  • Pharma Mar SA
  • Pharmaxis Ltd
  • Philogen SpA
  • Phio Pharmaceuticals Corp
  • Phosplatin Therapeutics LLC
  • Pionyr Immunotherapeutics Inc
  • PIQUR Therapeutics AG
  • PlantForm Corp
  • Plexxikon Inc
  • Plus Therapeutics Inc
  • PNP Therapeutics Inc
  • Polaris Pharmaceuticals Inc
  • Potenza Therapeutics Inc
  • Precigen Inc
  • Prelude Therapeutics Inc
  • PRISM Pharma Co Ltd
  • Privo Technologies Inc
  • Protheragen Inc
  • Provectus Biopharmaceuticals Inc
  • PsiOxus Therapeutics Ltd
  • Psivac Ltd
  • Puma Biotechnology Inc
  • Purple Biotech Ltd
  • QBiotics Group Ltd
  • Qilu Pharmaceutical Co Ltd
  • Qilu Puget Sound Biotherapeutics Corp
  • Qrono Inc
  • Quadriga BioSciences Inc
  • R-Pharm
  • Rakuten Medical Inc
  • RAPT Therapeutics Inc
  • RaQualia Pharma Inc
  • Refuge Biotechnologies Inc
  • Regeneron Pharmaceuticals Inc
  • RemeGen Co Ltd
  • Repertoire Immune Medicines Inc
  • Reven Pharmaceuticals Inc
  • Rubius Therapeutics Inc
  • Sanofi
  • Sareum Holdings Plc
  • Scancell Holdings Plc
  • Scopus BioPharma Inc
  • Seagen Inc
  • SEEKYO Therapeutics
  • Seven and Eight Biopharmaceuticals Corp
  • Shanghai De Novo Pharmatech Co Ltd
  • Shanghai GeneChem Co Ltd
  • Shanghai Henlius Biotech Inc
  • Shanghai Institute of Biological Products Co Ltd
  • Shanghai Jing Ze Biotechnology Co Ltd
  • Shanghai Junshi Bioscience Co Ltd
  • Shanghai Miracogen Inc
  • Shanghai Novamab Biopharmaceuticals Co Ltd
  • Shattuck Labs Inc
  • Shenghe (China) Biopharmaceutical Co Ltd
  • Shionogi & Co Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Silverback Therapeutics Inc
  • Simcha Therapeutics Inc
  • Sino Biopharmaceutical Ltd
  • Sirnaomics Inc
  • Sirona Therapeutics Inc
  • SL Bigen Inc
  • Smerud Medical Research International AS
  • SN BioScience
  • Sonnet BioTherapeutics Holdings Inc
  • Soricimed Biopharma Inc
  • Sotio AS
  • SQZ Biotechnologies Co
  • Starpharma Holdings Ltd
  • STAT3 Therapeutics Inc
  • Stcube Inc
  • Stella Pharmaceuticals Pvt Ltd
  • Sumitomo Dainippon Pharma Co Ltd
  • Sumitomo Dainippon Pharma Oncology, Inc
  • Sutro Biopharma Inc
  • SuviCa Inc
  • Suzhou Dingfu Target Biotechnology Co Ltd
  • Suzhou Maximum Bio-tech Co Ltd
  • Suzhou Neupharma Co Ltd
  • Suzhou Teligene Ltd
  • Suzhou Zanrong Pharmaceutical Technology Co Ltd
  • Suzhou Zelgen Biopharmaceutical Co Ltd
  • Sveikatal Inc
  • Symphogen A/S
  • Synermore Biologics Co Ltd
  • Synthorx Inc
  • Syntrix Biosystems Inc
  • Systimmune Inc
  • Tactical Therapeutics Inc
  • TAE Life Sciences LLC
  • Tailored Therapeutics LLC
  • Takeda Pharmaceutical Co Ltd
  • Takis Srl
  • Tallikut Pharmaceuticals Inc
  • TCR Cure Biopharma Technology Co Ltd
  • Telix Pharmaceuticals Ltd
  • TempestTx, Inc.
  • Tessa Therapeutics Ltd
  • Tetranov International Inc
  • Theralase Technologies Inc
  • Theravectys SA
  • Tmunity Therapeutics Inc
  • TOLREMO Therapeutics AG
  • Touchlight Genetics Ltd
  • Transgene SA
  • Treadwell Therapeutics Inc
  • Tuhura Biopharma Inc
  • Turning Point Therapeutics Inc
  • Turnstone Biologics Inc
  • Tvardi Therapeutics Inc
  • Tyme Inc
  • UbiVac LLC
  • UCB SA
  • Ultimovacs AS
  • United Immunity Co Ltd
  • Vaccinex Inc
  • VasGene Therapeutics Inc
  • Vault Pharma Inc
  • VCN Biosciences SL
  • Vectorite Biomedical Inc
  • Venus Remedies Ltd
  • Versameb AG
  • Viracta Therapeutics Inc
  • Viralytics Pty Ltd
  • Virion Therapeutics LLC
  • Virocure Inc
  • VM Discovery Inc
  • Voronoi Group
  • Vyriad Inc
  • Waterstone Hanxbio Pty Ltd
  • Wayshine Biopharma Inc
  • WindMIL Therapeutics Inc
  • Wugen Inc
  • Wuhan Binhui Biotechnology Co Ltd
  • Xbrane Biopharma AB
  • Xencor Inc
  • Xiangxue Life Sciences
  • XuanZhu Biological Technology Co Ltd
  • Xynomic Pharmaceuticals Holdings Inc
  • Y-Biologics Inc
  • Zhejiang Yangshengtang Biotech Co Ltd
  • Zymeworks Inc